StockStory.org on MSN
BAX Q3 Deep Dive: Mixed Segment Results and Lowered Guidance Drive Market Reaction
Healthcare company Baxter International (NYSE:BAX) in Q3 CY2025, but sales rose 5% year on year to $2.84 billion. Next ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results